Comparative bioavailability of two brands of oral sustained-release nitroglycerin tablets
- In: SIG: Bioavailability/Bioequivalence - Posters
- At: Basel (Switzerland) (2008)
- Type: Poster
- Poster code: BB-P-012
- By: GHANDFOROUSH-SATTARI, Mohammadreza (Tabriz University of Medical Sciences, Tabriz, Iran)
- Co-author(s): Valizadeh, Hadi (Tabriz University of Medical Sciences, TABRIZ, Iran)
Zakeri, Parvin (Tabriz University of Medical Sciences, TABRIZ, Iran)
Mashayekhi, Siminozar (Hematology and Oncology Research Centre, Tabriz, Iran, Iran) - Abstract:
Nitroglycerin (GTN, glyceryl trinitrate) has been used in the treatment of angina pectoris for more than a century. Following oral administration, GTN undergoes extensive first pass hepatic metabolism, thus for the pharmacokinetic study of oral GTN, its main two stable metabolites; 1,2-dinitroglycerin (1,2-GDN) and 1,3-dinitroglycerin (1,3-GDN)..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 4 October 2019